OxyHbMeter—a novel bedside medical device for monitoring cell-free hemoglobin in the cerebrospinal fluid—proof of principle

OxyHbMeter—a novel bedside medical device for monitoring cell-free hemoglobin in the cerebrospinal fluid—proof of principle

Delayed cerebral ischemia (DCI) occurs in up to one third of patients suffering from aneurysmal subarachnoid hemorrhage (aSAH). Untreated, it leads to secondary cerebral infarctions and is frequently associated with death or severe disability. After aneurysm rupture, erythrocytes in the subarachnoid...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Nikolaos Tachatos, Jan Folkard Willms, Michael Sebastian Gerlt, Kiran Kuruvithadam, Michael Hugelshofer, Kevin Akeret, Jeremy Deuel, Emanuela Keller, Marianne Schmid Daners
Formaat: Artikel
Taal:English
Gepubliceerd in: Frontiers Media S.A. 2024-04-01
Reeks:Frontiers in Medical Technology
Onderwerpen:
delayed cerebral ischemia
aneurysmal subarachnoid hemorrhage
microfluidics
acoustic particle manipulation
cell separation
point of care device
Online toegang:https://www.frontiersin.org/articles/10.3389/fmedt.2024.1274058/full

Internet

https://www.frontiersin.org/articles/10.3389/fmedt.2024.1274058/full

Gelijkaardige items